YCY
NYSE · N/A
Aa Mission Acquisition-A
$10.24
-0.01 (-0.10%)
Open$10.24
Previous Close$10.25
Day High$10.25
Day Low$10.24
52W High$10.25
52W Low$9.90
Volume—
Avg Volume26.8K
Market Cap121.39M
P/E Ratio464.95
EPS$0.00
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 39.01M | 40.32M | 32.67M |
| Net Income | 1.80M | 2.30M | 1.57M |
| Profit Margin | 4.6% | 5.7% | 4.8% |
| EBITDA | 3.33M | 3.18M | 2.52M |
| Free Cash Flow | 1.88M | 2.00M | 1.33M |
| Rev Growth | +9.1% | -6.2% | +4.8% |
| Debt/Equity | 0.57 | 0.61 | 0.48 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.02 | +8.24% | — | 1.41B |
| PICS | Pics Nv | $10.27 | +0.49% | 6.6 | 1.48B |
| DMII | Drugs Made In America Acquis | $10.12 | -0.10% | 75.2 | 645.28M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.73 | -0.05% | 35.5 | 336.67M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | +0.48% | 57.9 | 595.50M |